Propafenone- vs. amiodarone-associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure.
Saved in:
| Title: | Propafenone- vs. amiodarone-associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure. |
|---|---|
| Authors: | Lin YC; Department of Pharmacy, Taipei Medical University Hospital, Taipei, Taiwan.; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan., Chen BL; Department of Pharmacy, Taipei Medical University Hospital, Taipei, Taiwan.; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan., Hsu CY; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.; Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., Chen LY; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan., Lin SJ; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan., Lip GYH; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.; Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Chien LN; Institute of Health and Welfare Policy, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Huang CY; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.; Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Biomedical Science and Engineering, National Central University, Taoyuan City, Taiwan. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2025 Sep; Vol. 91 (9), pp. 2567-2575. Date of Electronic Publication: 2025 Apr 27. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40289259 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Propafenone- vs. amiodarone-associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lin+YC%22">Lin YC</searchLink>; Department of Pharmacy, Taipei Medical University Hospital, Taipei, Taiwan.; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+BL%22">Chen BL</searchLink>; Department of Pharmacy, Taipei Medical University Hospital, Taipei, Taiwan.; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsu+CY%22">Hsu CY</searchLink>; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.; Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+LY%22">Chen LY</searchLink>; Health Data Analytics and Statistics Center, Office of Data Science, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+SJ%22">Lin SJ</searchLink>; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lip+GYH%22">Lip GYH</searchLink>; Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK.; Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Chien+LN%22">Chien LN</searchLink>; Institute of Health and Welfare Policy, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+CY%22">Huang CY</searchLink>; Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.; Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan.; Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Biomedical Science and Engineering, National Central University, Taoyuan City, Taiwan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2025 Sep; Vol. 91 (9), pp. 2567-2575. <i>Date of Electronic Publication: </i>2025 Apr 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40289259 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/bcp.70068 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2567 Titles: – TitleFull: Propafenone- vs. amiodarone-associated adverse cardiac outcomes in patients with atrial fibrillation and heart failure. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lin YC – PersonEntity: Name: NameFull: Chen BL – PersonEntity: Name: NameFull: Hsu CY – PersonEntity: Name: NameFull: Chen LY – PersonEntity: Name: NameFull: Lin SJ – PersonEntity: Name: NameFull: Lip GYH – PersonEntity: Name: NameFull: Chien LN – PersonEntity: Name: NameFull: Huang CY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2025 Sep Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1365-2125 Numbering: – Type: volume Value: 91 – Type: issue Value: 9 Titles: – TitleFull: British journal of clinical pharmacology Type: main |
| ResultId | 1 |